OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 32 filers reported holding OCUPHIRE PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $37,979 | +1695.7% | 8,751 | +1451.6% | 0.00% | – |
| Q1 2023 | $2,115 | -29.5% | 564 | -66.8% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 1,700 | -31.1% | 0.00% | – |
| Q2 2022 | $5,000 | -73.7% | 2,466 | -57.1% | 0.00% | – |
| Q1 2022 | $19,000 | -29.6% | 5,748 | -19.6% | 0.00% | – |
| Q4 2021 | $27,000 | -34.1% | 7,145 | -8.8% | 0.00% | – |
| Q3 2021 | $41,000 | +36.7% | 7,838 | +41.4% | 0.00% | – |
| Q2 2021 | $30,000 | +172.7% | 5,542 | +206.2% | 0.00% | – |
| Q1 2021 | $11,000 | – | 1,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 320,332 | $641,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 540,348 | $1,086,000 | 0.06% |
| Eidelman Virant Capital | 25,000 | $51,000 | 0.04% |
| Diametric Capital, LP | 24,548 | $49,000 | 0.02% |
| MAI Capital Management | 356,948 | $717,000 | 0.01% |
| Bedel Financial Consulting, Inc. | 15,000 | $31,000 | 0.01% |
| Warberg Asset Management LLC | 21,000 | $42,000 | 0.01% |
| Cornerstone Capital, Inc. | 13,857 | $28,000 | 0.00% |
| Stokes Family Office, LLC | 12,120 | $24,000 | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $2,000 | 0.00% |